Deuterium Magnetic Resonance Imaging (dMRI) for In Vivo Visualization of Rapidly-Dividing Cells

The National Cancer Institute seeks licensees for a method for in vivo visualization of rapidly-dividing cells and dynamic measurement of cellular kinetics using Deuterium Magnetic Resonance Imaging (dMRI).IC: NCINIH Ref. No.: E-188-2016Advantages: Less invasive alternative to current diagnostic procedures, such as biopsies: decreases patient discomfort.Faster detection method can  improve patient responses to treatment and survival ratesApplications: Non-invasive diagnostic, non-radioactive labeling-imaging approach for many cell types, including neoplastic cells.Development Status: Discovery (Lead Identification)Updated On: Feb 2, 2018Provider Classifications: Date Published: Thursday, February 2, 2017Publications: Patent Application: 62/414,554PCT/US2017/058856PCT/US2017/058856Patent Authority: USUSLicensing Contacts: Lead Inventor: Inventor IC: NCIInventor Lab URL: https://ccr.cancer.gov/Experimental-Transplantation-and-Immunology-Branch/nataliya-p-buxbaumInv Is lead: LPM Phone: [phone]LPM Email: [e-mail] Classification: Devices DiagnosticsDTDT Description: Devices DiagnosticsPat Filing Date: 2016-10-16T00:00:002017-10-27T00:00:002017-10-27T00:00:00Collaboration Sought: YesInstitute or Center: NCICollaboration Opportunity: Licensing onlyInventor First Name: NataliyaInventor Last Name: Buxbaum

Source: NIH OTT Licensing Opportunities - February 2, 2017 Category: Research Authors: ajoyprabhu3 Source Type: research